93 related articles for article (PubMed ID: 22622950)
1. Management and prognosis of clear cell borderline ovarian tumor.
Uzan C; Dufeu-Lefebvre M; Fauvet R; Gouy S; Duvillard P; Darai E; Morice P
Int J Gynecol Cancer; 2012 Jul; 22(6):993-9. PubMed ID: 22622950
[TBL] [Abstract][Full Text] [Related]
2. Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management.
Ricotta G; Maulard A; Candiani M; Genestie C; Pautier P; Leary A; Chargari C; Mangili G; Morice P; Gouy S
Ann Surg Oncol; 2022 Feb; 29(2):1165-1170. PubMed ID: 34596794
[TBL] [Abstract][Full Text] [Related]
3. Management and prognosis of borderline ovarian Brenner tumors.
Uzan C; Dufeu-Lefebvre M; Fauvet R; Gouy S; Duvillard P; Darai E; Morice P
Int J Gynecol Cancer; 2012 Oct; 22(8):1332-6. PubMed ID: 22954784
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of a bilateral ovarian clear cell borderline adenofibromatous tumor.
Narese F; Virzì G; Narese D; Orlando AA; Vinti D; Virzì V
Clin Ter; 2014; 165(5):249-51. PubMed ID: 25366944
[TBL] [Abstract][Full Text] [Related]
5. Management and prognosis of endometrioid borderline tumors of the ovary.
Uzan C; Berretta R; Rolla M; Gouy S; Fauvet R; Darai E; Duvillard P; Morice P
Surg Oncol; 2012 Sep; 21(3):178-84. PubMed ID: 22418038
[TBL] [Abstract][Full Text] [Related]
6. Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements.
Ricotta G; Maulard A; Candiani M; Scherrier S; Genestie C; Pautier P; Leary A; Chargari C; Mangili G; Morice P; Gouy S
Ann Surg Oncol; 2022 Sep; 29(9):5894-5903. PubMed ID: 35590116
[TBL] [Abstract][Full Text] [Related]
7. Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
Ricotta G; Maulard A; Genestie C; Pautier P; Leary A; Chargari C; Candiani M; Morice P; Gouy S
Ann Surg Oncol; 2021 Oct; 28(11):6714-6720. PubMed ID: 33768396
[TBL] [Abstract][Full Text] [Related]
8. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study.
Scarfone G; Bergamini A; Noli S; Villa A; Cipriani S; Taccagni G; Vigano' P; Candiani M; Parazzini F; Mangili G
Gynecol Oncol; 2014 Jun; 133(3):480-4. PubMed ID: 24642093
[TBL] [Abstract][Full Text] [Related]
10. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
Silva EG; Young RH
Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
[TBL] [Abstract][Full Text] [Related]
11. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
Chew S; Tham KF; Ratnam SS
Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
[TBL] [Abstract][Full Text] [Related]
12. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pure and mixed-type clear cell carcinoma of the ovary: a clinicopathological analysis of 341 Chinese patients.
Ye S; You Y; Yang J; Cao D; Bai H; Huang H; Wu M; Chen J; Lang J; Shen K
Int J Gynecol Cancer; 2014 Nov; 24(9):1590-6. PubMed ID: 25254564
[TBL] [Abstract][Full Text] [Related]
16. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
17. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
[TBL] [Abstract][Full Text] [Related]
18. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
19. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
20. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S;
Eur J Cancer; 2013 May; 49(8):1905-14. PubMed ID: 23490647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
